Elmiron Vision Loss Litigation

Case: In Re: Elmiron Products Liability Litigation, case number 2:20-md-02973
Court: United States District Court, District of New Jersey


Wallace Miller represents individuals who have developed vision issues as a result of the bladder pain medication Elmiron.

Elmiron is a medication prescribed to prevent the pain associated with a bladder condition called interstitial cystitis (IC), a condition that affects millions of Americans each year, the majority of whom are women. Elmiron is the primary pharmaceutical treatment for bladder pain associated with IC and is the only treatment approved for this condition in the US. Elmiron is now linked to maculopathy and other life-altering eye injuries. Elmiron contains an ingredient known as PPS (pentosan polysulfate sodium), and there is a growing body of scientific evidence that shows long term use of PPS can potentially cause maculopathy, which can lead to permanent eye damage and vision loss. Medical studies have found that a specific type of maculopathy, known as pigmentary maculopathy, is linked to Elmiron use. There is no cure for pigmentary maculopathy, and damage is often irreversible.

Elmiron is still being marketied by manufacturer Janssen as a treatment with only minor side-effects. As medical literature is now showing, however, this is not the case; many individuals are experiencing irreversible vision damage. Plaintiffs in ongoing Elmiron vision lawsuits claim the manufacturer was aware of the potential harm and failed to disclose this risk until recently.

Wallace Miller believes the manufacturer of Elmiron needs to be held accountable for this wrong. Our team is hard at work to secure recoveries for our clients suffering vision issues as a result of Elmiron. If you believe you have been harmed, contact our attorneys today.